.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
BBB disruption mechanisms serve as a primary catalyst for various neurological disorders. Scientists now understand how brain-infiltrating T cell responses engage the neurovascular unit (NVU). This engagement often leads to neuroinflammation and significant vascular leakage. Furthermore, the role of antigen presentation is crucial in this process. Consequently, discrete MHC class I and class II molecules on NVU cells govern how T cells enter and remain in the brain. Moreover, these interactions determine the extent of barrier disruption. Thus, clinicians must consider these pathways when managing patients with conditions like multiple sclerosis or Parkinson's.
In addition, specific HLA genes are linked to these inflammatory processes. Therefore, genetic profiling may offer insights into disease susceptibility. Finally, understanding these mechanisms allows for more targeted therapeutic interventions. This review highlights how the immune system contributes to neuropathology across diverse diseases. Researchers are now focusing on the specific cellular components of the NVU that regulate these responses. This context is vital for understanding vascular leakage in diseases as diverse as cerebral malaria and COVID-19.
MHC class I and II molecules on neurovascular unit cells regulate T cell entry and retention, which directly impacts barrier integrity and leads to neuroinflammation.
Numerous diseases are linked to barrier disruption, including multiple sclerosis, Parkinson's disease, schizophrenia, cerebral malaria, and COVID-19.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of how brain-infiltrating T cells and MHC molecules drive blood-brain barrier disruption and neuroinflammation in diverse neurological diseases....
5 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
